{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T21:26:55Z","timestamp":1775597215343,"version":"3.50.1"},"reference-count":30,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000871","name":"Mayo Clinic","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100000871","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","mayoclinicproceedings.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Mayo Clinic Proceedings"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1016\/j.mayocp.2020.04.017","type":"journal-article","created":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T08:03:11Z","timestamp":1590998591000},"page":"1268-1275","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Breast Cancer Risk Assessment"],"prefix":"10.1016","volume":"95","author":[{"given":"Adelaide H.","family":"McClintock","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna L.","family":"Golob","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary B.","family":"Laya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.mayocp.2020.04.017_bib1","doi-asserted-by":"crossref","first-page":"279","DOI":"10.7326\/M15-2886","article-title":"Screening for Breast Cancer: U.S. Preventive Services Task Force recommendation statement","volume":"164","author":"Siu","year":"2016","journal-title":"Ann Intern Med"},{"issue":"6","key":"10.1016\/j.mayocp.2020.04.017_bib2","article-title":"Breast cancer screening in the precision medicine era: risk-based screening in a population-based trial","volume":"109","author":"Shieh","year":"2017","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.mayocp.2020.04.017_bib3","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1056\/NEJMsr1407164","article-title":"Atypical hyperplasia of the breast: risk assessment and management options","author":"Hartmann","year":"2015","journal-title":"N\u00a0Engl J Med"},{"issue":"7","key":"10.1016\/j.mayocp.2020.04.017_bib4","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1001\/jama.2019.10987","article-title":"Risk assessment, genetic counseling, and genetic testing for BRCA-related cancer: US Preventive Services Task Force recommendation statement","volume":"322","author":"Owens","year":"2019","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.mayocp.2020.04.017_bib5","doi-asserted-by":"crossref","first-page":"9","DOI":"10.6004\/jnccn.2017.0003","article-title":"Genetic\/familial high-risk assessment: breast and ovarian","volume":"15","author":"Daly","year":"2017","journal-title":"J\u00a0Natl Compr Canc Netw"},{"key":"10.1016\/j.mayocp.2020.04.017_bib6","series-title":"Hereditary Cancer Syndromes and Risk Assessment: Number 793","year":"2019"},{"issue":"4","key":"10.1016\/j.mayocp.2020.04.017_bib7","doi-asserted-by":"crossref","first-page":"380","DOI":"10.6004\/jnccn.2020.0017","article-title":"NCCN Guidelines Insights: Genetic\/familial high-risk assessment: breast, ovarian, and pancreatic cancer, version 1.2020","volume":"18","author":"Daly","year":"2020","journal-title":"J\u00a0Natl Compr Canc Netw"},{"issue":"24","key":"10.1016\/j.mayocp.2020.04.017_bib8","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1093\/jnci\/81.24.1879","article-title":"Projecting individualized probabilities of developing breast cancer for white females who are being examined annually","volume":"81","author":"Gail","year":"1989","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"18","key":"10.1016\/j.mayocp.2020.04.017_bib9","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1093\/jnci\/91.18.1541","article-title":"Validation studies for models projecting the risk of invasive and total breast cancer incidence","volume":"91","author":"Costantino","year":"1999","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"5","key":"10.1016\/j.mayocp.2020.04.017_bib10","doi-asserted-by":"crossref","first-page":"337","DOI":"10.7326\/0003-4819-148-5-200803040-00004","article-title":"Using clinical factors and mammographic breast density to estimate breast cancer risk: development and validation of a new predictive model","volume":"148","author":"Tice","year":"2008","journal-title":"Ann Intern Med"},{"issue":"7","key":"10.1016\/j.mayocp.2020.04.017_bib11","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1002\/sim.1668","article-title":"A\u00a0breast cancer prediction model incorporating familial and personal risk factors","volume":"23","author":"Tyrer","year":"2004","journal-title":"Stat Med"},{"key":"10.1016\/j.mayocp.2020.04.017_bib12","series-title":"Models for Assessment of Breast Cancer Risk","author":"Cuzick","year":"2016"},{"issue":"1","key":"10.1016\/j.mayocp.2020.04.017_bib13","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s13058-018-0947-5","article-title":"Assessment of performance of the Gail model for predicting breast cancer risk: a systematic review and meta-analysis with trial sequential analysis","volume":"20","author":"Wang","year":"2018","journal-title":"Breast Cancer Res"},{"issue":"17","key":"10.1016\/j.mayocp.2020.04.017_bib14","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.1200\/JCO.2010.33.0258","article-title":"Benefit\/risk assessment for breast cancer chemoprevention with raloxifene or tamoxifen for women age 50 years or older","volume":"29","author":"Freedman","year":"2011","journal-title":"J\u00a0Clin Oncol"},{"issue":"28","key":"10.1016\/j.mayocp.2020.04.017_bib15","doi-asserted-by":"crossref","first-page":"3137","DOI":"10.1200\/JCO.2015.60.8869","article-title":"Breast density and benign breast disease: risk assessment to identify women at high risk of breast cancer","volume":"33","author":"Tice","year":"2015","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.mayocp.2020.04.017_bib16","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1056\/NEJMoa062790","article-title":"Mammographic density and the risk and detection of breast cancer","volume":"356","author":"Boyd","year":"2007","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.mayocp.2020.04.017_bib17","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1007\/s10549-019-05167-2","article-title":"Validation of the breast cancer surveillance consortium model of breast cancer risk","volume":"175","author":"Tice","year":"2019","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"10.1016\/j.mayocp.2020.04.017_bib18","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1186\/s13058-015-0653-5","article-title":"Mammographic density adds accuracy to both the Tyrer-Cuzick and Gail breast cancer risk models in a prospective UK screening cohort","volume":"17","author":"Brentnall","year":"2015","journal-title":"Breast Cancer Res"},{"issue":"9","key":"10.1016\/j.mayocp.2020.04.017_bib19","doi-asserted-by":"crossref","first-page":"e180174","DOI":"10.1001\/jamaoncol.2018.0174","article-title":"Long-term accuracy of breast cancer risk assessment combining classic risk factors and breast density","volume":"4","author":"Brentnall","year":"2018","journal-title":"JAMA Oncol"},{"issue":"33","key":"10.1016\/j.mayocp.2020.04.017_bib20","doi-asserted-by":"crossref","first-page":"3152","DOI":"10.1200\/JCO.19.01472","article-title":"Use of endocrine therapy for breast cancer risk reduction: ASCO clinical practice guideline update","volume":"37","author":"Visvanathan","year":"2019","journal-title":"J\u00a0Clin Oncol"},{"issue":"3 Pt A","key":"10.1016\/j.mayocp.2020.04.017_bib21","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.jacr.2017.11.034","article-title":"Breast cancer screening in women at higher-than-average risk: recommendations from the ACR","volume":"15","author":"Monticciolo","year":"2018","journal-title":"J\u00a0Am Coll Radiol"},{"issue":"2","key":"10.1016\/j.mayocp.2020.04.017_bib22","first-page":"75","article-title":"American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography","volume":"57","author":"Saslow","year":"2007","journal-title":"CA Cancer J Clin"},{"issue":"10","key":"10.1016\/j.mayocp.2020.04.017_bib23","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.6004\/jnccn.2009.0070","article-title":"NCCN clinical practice guidelines in oncology: breast cancer screening and diagnosis","volume":"7","author":"Bevers","year":"2009","journal-title":"J\u00a0Natl Compr Canc Netw"},{"issue":"9","key":"10.1016\/j.mayocp.2020.04.017_bib24","doi-asserted-by":"crossref","first-page":"671","DOI":"10.7326\/0003-4819-148-9-200805060-00007","article-title":"Systematic review: using magnetic resonance imaging to screen women at high risk for breast cancer","volume":"148","author":"Warner","year":"2008","journal-title":"Ann Intern Med"},{"issue":"3","key":"10.1016\/j.mayocp.2020.04.017_bib25","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1007\/s10549-014-2931-9","article-title":"MRI breast screening in high-risk women: cancer detection and survival analysis","volume":"145","author":"Evans","year":"2014","journal-title":"Breast Cancer Res Treat"},{"issue":"15","key":"10.1016\/j.mayocp.2020.04.017_bib26","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1200\/JCO.2017.35.15_suppl.1508","article-title":"Survival outcomes of screening with breast MRI in high-risk women","volume":"35","author":"Bae","year":"2017","journal-title":"J\u00a0Clin Oncol"},{"issue":"18","key":"10.1016\/j.mayocp.2020.04.017_bib27","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1001\/jama.2018.13362","article-title":"Gadolinium retention after contrast-enhanced MRI","volume":"320","author":"Levine","year":"2020","journal-title":"JAMA"},{"issue":"9","key":"10.1016\/j.mayocp.2020.04.017_bib28","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1001\/jama.2019.11885","article-title":"Medication use to reduce risk of breast cancer: US Preventive Services Task Force Recommendation Statement","volume":"322","year":"2019","journal-title":"JAMA"},{"issue":"23","key":"10.1016\/j.mayocp.2020.04.017_bib29","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.1001\/jama.295.23.joc60074","article-title":"Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial","volume":"295","author":"Vogel","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.mayocp.2020.04.017_bib30","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1056\/NEJMoa1903986","article-title":"Supplemental MRI screening for women with extremely dense breast tissue","volume":"381","author":"Bakker","year":"2019","journal-title":"N\u00a0Engl J Med"}],"container-title":["Mayo Clinic Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619620303876?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619620303876?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T01:33:13Z","timestamp":1758418393000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025619620303876"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":30,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["S0025619620303876"],"URL":"https:\/\/doi.org\/10.1016\/j.mayocp.2020.04.017","relation":{},"ISSN":["0025-6196"],"issn-type":[{"value":"0025-6196","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Breast Cancer Risk Assessment","name":"articletitle","label":"Article Title"},{"value":"Mayo Clinic Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mayocp.2020.04.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Mayo Foundation for Medical Education and Research","name":"copyright","label":"Copyright"}]}}